87
Views
37
CrossRef citations to date
0
Altmetric
Original Research

Outpatient treatment of low-risk venous thromboembolism with monotherapy oral anticoagulation: patient quality of life outcomes and clinician acceptance

, &
Pages 561-569 | Published online: 15 Apr 2016

References

  • BeamDMKahlerZPKlineJAImmediate discharge and home treatment of low risk venous thromboembolism diagnosed in two U.S. emergency departments with rivaroxaban: a one- year preplanned analysisAcad Emerg Med20152278879526113241
  • KabrhelCOkechukwuIHariharanPFactors associated with clinical deterioration shortly after PEThorax20146983584224846902
  • YooHHQueluzTHElDROutpatient versus inpatient treatment for acute pulmonary embolismCochrane Database Syst Rev201411CD01001925411774
  • KearonCAklEAComerotaAJAmerican College of Chest PhysiciansAntithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest2012141e419Se494S22315268
  • KahnSRShbakloHLampingDLDeterminants of health-related quality of life during the 2 years following deep vein thrombosisJ Thromb Haemost200861105111218466316
  • KlokFAvan KralingenKWvan DijkAPQuality of life in long-term survivors of acute pulmonary embolismChest20101381432144020495104
  • KlineJARoyPMThanMPDerivation and validation of a multivariate model to predict mortality from pulmonary embolism with cancer: the POMPE-C toolThromb Res2012129e194e19922475313
  • SchulmanSKearonCPSubcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patientsJ Thromb Haemost2005369269415842354
  • HaysRDSherbourneCDMazelRMThe RAND 36-item health survey 1.0Health Econ199322172278275167
  • KlineJAKabrhelCCourtneyDMTreatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at three months (TOPCOAT): multicenter double-blind, placebo-controlled randomized trialJ Thromb Haemost201412549568
  • CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis1987403733833558716
  • LampingDLSchroterSKurzXKahnSRAbenhaimLEvaluation of outcomes in chronic venous disorders of the leg: development of a scientifically rigorous, patient-reported measure of symptoms and quality of life [see comment]J Vasc Surg20033741041912563215
  • KahnSRLampingDLDucruetTVETO Study investigatorsVEINES-QOL/Sym questionnaire was a reliable and valid disease-specific quality of life measure for deep venous thrombosisJ Clin Epidemiol2006591049105616980144
  • LocadiaMBossuytPMStalmeierPFTreatment of venous thromboembolism with vitamin K antagonists: patients’ health state valuations and treatment preferencesThromb Haemost2004921336134115583742
  • HOGGKKimptonMCarrierMCoyleDForgieMWellsPEstimating quality of life in acute venous thrombosisJAMA Intern Med20131731067107223689427
  • ZondagWden ExterPLCrobachMJHestia Study InvestigatorsComparison of two methods for selection of out of hospital treatment in patients with acute pulmonary embolismThromb Haemost2013109475223138355
  • ZondagWVingerhoetsLMDurianMFHestia Study InvestigatorsHestia criteria can safely select patients with pulmonary embolism for outpatient treatment irrespective of right ventricular functionJ Thromb Haemost20131168669223336721